Health and medicine

AstraZeneca has acquired exclusive global rights to develop and commercialize Dizal Pharmaceutical’s marketed lung cance…
Genetic Engineering & Biotechnology News · —

Preclinical study results suggest that targeting Hippo signaling may help address treatment resistance in acute myeloid…
Genetic Engineering & Biotechnology News · —

Organoid platform uncovers chronic pancreatitis development and identifies possible therapeutic strategies.
Genetic Engineering & Biotechnology News · —

Living cells inside electronic sensors offer otherwise unavailable data for vat fermentation and continuous processing.
Genetic Engineering & Biotechnology News · —

Modular mechanistic modeling enhances mRNA IVT optimization and manufacturing efficiency through predictive bioprocessin…
Genetic Engineering & Biotechnology News · —

In vivo CAR T gene therapies are using viruses or lipid nanoparticles with possible off-target effects.
Genetic Engineering & Biotechnology News · —

Study findings suggest that smoking, and potentially air pollution, might make it easier for micro- and nanoplastics to…
Genetic Engineering & Biotechnology News · —

Results point to potential to restore vision with drugs, non-invasively, reversibly, via a mechanism that is independent…
Genetic Engineering & Biotechnology News · —

The team’s strategy—called antibody–ADC click—relies on the rapid ligation between trans‑cyclooctene (TCO) and tetrazine…
Genetic Engineering & Biotechnology News · —

Secreting proteins from cells into surrounding tissue, or into circulation, opens new treatment opportunities beyond cla…
Genetic Engineering & Biotechnology News · —

A first-in-human KRAS-targeted pancreatic cancer vaccine elicited durable immune responses in 90% of participants, and s…
Genetic Engineering & Biotechnology News · —

This week, editors discuss a stem cell therapy clinical trial for Parkinson’s, billion-dollar investments in AI, and Ver…
Genetic Engineering & Biotechnology News · —